ID

30395

Beschrijving

Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT00829205

Link

https://clinicaltrials.gov/show/NCT00829205

Trefwoorden

Versies (1)
  1. 02-06-18 02-06-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

2 juni 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Lymphoma NCT00829205

Engels

Eligibility Lymphoma NCT00829205

1 Formulieren  
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00829205
Criteria
Beschrijving

Criteria

histologically confirmed, cd20+, diffuse large b-cell lymphoma (dlbcl) according to who lymphoma classification
Beschrijving

Diffuse Large B-Cell Lymphoma CD20 positive WHO tumor classification

Datatype

boolean

Alias
UMLS CUI [1,1]
C0079744
UMLS CUI [1,2]
C0882818
UMLS CUI [1,3]
C1301142
histological transformation of a previously known indolent lymphoma allowed
Beschrijving

Indolent Lymphoma Transformation

Datatype

boolean

Alias
UMLS CUI [1,1]
C1334170
UMLS CUI [1,2]
C1536010
biopsy-proven dlbcl arising from an indolent lymphoma not diagnosed previously allowed
Beschrijving

Diffuse Large B-Cell Lymphoma Origin Indolent Lymphoma

Datatype

boolean

Alias
UMLS CUI [1,1]
C0079744
UMLS CUI [1,2]
C0439659
UMLS CUI [1,3]
C1334170
disease in first relapse after complete remission, partial response (pr), or less than a pr after first-line of treatment
Beschrijving

First Relapse Post Complete remission | Partial response | Less Than Partial response Post First line treatment

Datatype

boolean

Alias
UMLS CUI [1,1]
C4054953
UMLS CUI [1,2]
C0687676
UMLS CUI [1,3]
C0677874
UMLS CUI [2]
C1521726
UMLS CUI [3,1]
C0439092
UMLS CUI [3,2]
C1521726
UMLS CUI [3,3]
C0687676
UMLS CUI [3,4]
C1708063
no primary cns lymphoma
Beschrijving

Primary central nervous system lymphoma Absent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0280803
UMLS CUI [1,2]
C0332197
patient characteristics:
Beschrijving

Client Characteristics

Datatype

boolean

Alias
UMLS CUI [1]
C0815172
ecog performance status 0-2
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy > 3 months
Beschrijving

Life Expectancy

Datatype

boolean

Alias
UMLS CUI [1]
C0023671
serum creatinine < 150 μmol/l
Beschrijving

Creatinine measurement, serum

Datatype

boolean

Alias
UMLS CUI [1]
C0201976
serum bilirubin < 35 μmol/l
Beschrijving

Serum total bilirubin measurement

Datatype

boolean

Alias
UMLS CUI [1]
C1278039
transaminases < 2.5 times upper limit of normal (unless attributed to lymphoma)
Beschrijving

Transaminase Assay | Exception Relationship Lymphoma

Datatype

boolean

Alias
UMLS CUI [1]
C0919834
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0439849
UMLS CUI [2,3]
C0024299
not pregnant or nursing
Beschrijving

Pregnancy Absent | Breast Feeding Absent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
negative pregnancy test
Beschrijving

Pregnancy test negative

Datatype

boolean

Alias
UMLS CUI [1]
C0427780
fertile patients must use effective contraception
Beschrijving

Fertility Contraceptive methods

Datatype

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
no contraindication to any of the drugs contained in the immunochemotherapy regimen
Beschrijving

Exclusion | Medical contraindication Pharmaceutical Preparations Immunochemotherapy

Datatype

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C4087148
no other malignancy within the past 2 years, except basal cell or squamous cell carcinoma of the skin or carcinoma in situ of the cervix
Beschrijving

Exclusion Cancer Other | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin | Exception Carcinoma in situ of uterine cervix

Datatype

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0553723
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0851140
no other serious active disease that, in the opinion of the investigator, would preclude the patient from having conventional chemotherapy
Beschrijving

Exclusion | Disease Serious Preventing Chemotherapy

Datatype

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C1292733
UMLS CUI [2,4]
C0392920
no hiv positivity
Beschrijving

Exclusion HIV Seropositivity

Datatype

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0019699
no medical or psychiatric conditions that compromise the patient's ability to give informed consent
Beschrijving

Exclusion Criteria | Medical condition compromises Informed Consent | Mental condition compromises Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C2945640
UMLS CUI [2,3]
C0021430
UMLS CUI [3,1]
C3840291
UMLS CUI [3,2]
C2945640
UMLS CUI [3,3]
C0021430
prior concurrent therapy:
Beschrijving

Therapeutic procedure

Datatype

boolean

Alias
UMLS CUI [1]
C0087111
not specified
Beschrijving

Unspecified

Datatype

boolean

Alias
UMLS CUI [1]
C0205370
Terug naar het begin van de pagina

Similar models

Eligibility Lymphoma NCT00829205

1 Formulieren
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00829205
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Diffuse Large B-Cell Lymphoma CD20 positive WHO tumor classification
Item
histologically confirmed, cd20+, diffuse large b-cell lymphoma (dlbcl) according to who lymphoma classification
boolean
C0079744 (UMLS CUI [1,1])
C0882818 (UMLS CUI [1,2])
C1301142 (UMLS CUI [1,3])
Indolent Lymphoma Transformation
Item
histological transformation of a previously known indolent lymphoma allowed
boolean
C1334170 (UMLS CUI [1,1])
C1536010 (UMLS CUI [1,2])
Diffuse Large B-Cell Lymphoma Origin Indolent Lymphoma
Item
biopsy-proven dlbcl arising from an indolent lymphoma not diagnosed previously allowed
boolean
C0079744 (UMLS CUI [1,1])
C0439659 (UMLS CUI [1,2])
C1334170 (UMLS CUI [1,3])
First Relapse Post Complete remission | Partial response | Less Than Partial response Post First line treatment
Item
disease in first relapse after complete remission, partial response (pr), or less than a pr after first-line of treatment
boolean
C4054953 (UMLS CUI [1,1])
C0687676 (UMLS CUI [1,2])
C0677874 (UMLS CUI [1,3])
C1521726 (UMLS CUI [2])
C0439092 (UMLS CUI [3,1])
C1521726 (UMLS CUI [3,2])
C0687676 (UMLS CUI [3,3])
C1708063 (UMLS CUI [3,4])
Primary central nervous system lymphoma Absent
Item
no primary cns lymphoma
boolean
C0280803 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy > 3 months
boolean
C0023671 (UMLS CUI [1])
Creatinine measurement, serum
Item
serum creatinine < 150 μmol/l
boolean
C0201976 (UMLS CUI [1])
Serum total bilirubin measurement
Item
serum bilirubin < 35 μmol/l
boolean
C1278039 (UMLS CUI [1])
Transaminase Assay | Exception Relationship Lymphoma
Item
transaminases < 2.5 times upper limit of normal (unless attributed to lymphoma)
boolean
C0919834 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0439849 (UMLS CUI [2,2])
C0024299 (UMLS CUI [2,3])
Pregnancy Absent | Breast Feeding Absent
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Pregnancy test negative
Item
negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Exclusion | Medical contraindication Pharmaceutical Preparations Immunochemotherapy
Item
no contraindication to any of the drugs contained in the immunochemotherapy regimen
boolean
C2828389 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C4087148 (UMLS CUI [2,3])
Exclusion Cancer Other | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin | Exception Carcinoma in situ of uterine cervix
Item
no other malignancy within the past 2 years, except basal cell or squamous cell carcinoma of the skin or carcinoma in situ of the cervix
boolean
C2828389 (UMLS CUI [1,1])
C1707251 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0851140 (UMLS CUI [4,2])
Exclusion | Disease Serious Preventing Chemotherapy
Item
no other serious active disease that, in the opinion of the investigator, would preclude the patient from having conventional chemotherapy
boolean
C2828389 (UMLS CUI [1])
C0012634 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C1292733 (UMLS CUI [2,3])
C0392920 (UMLS CUI [2,4])
Exclusion HIV Seropositivity
Item
no hiv positivity
boolean
C2828389 (UMLS CUI [1,1])
C0019699 (UMLS CUI [1,2])
Exclusion Criteria | Medical condition compromises Informed Consent | Mental condition compromises Informed Consent
Item
no medical or psychiatric conditions that compromise the patient's ability to give informed consent
boolean
C0680251 (UMLS CUI [1])
C3843040 (UMLS CUI [2,1])
C2945640 (UMLS CUI [2,2])
C0021430 (UMLS CUI [2,3])
C3840291 (UMLS CUI [3,1])
C2945640 (UMLS CUI [3,2])
C0021430 (UMLS CUI [3,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial